We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.
There are 146 start-ups with an aggregate funding of $8.1b. The average funding per company in this subset is $117.0m.
Last update to the database: Feb 18, 2025. See changelog.
Mammoth Biosciences is an American company based in San Francisco founded on June 1, 2017. Mammoth Biosciences uses CRISPR technology to develop bio-sensing technologies for diagnostics in industries such as healthcare, agriculture, manufacturing, and forensics and genome editing therapeutics.
5
Funding Rounds
$263.1m
Money raised
Finless Foods is a biotechnology company producing cultured marine animal food products through implementing cellular agriculture and manufacturing technologies.
9
Funding Rounds
$37.5m
Money raised
An Israeli startup company that is working to make sustainable "animal-free" cell-based meat products available at the local level by adapting the distributed manufacturing model
4
Funding Rounds
$390.0m
Money raised
Aleph Farms is an Israeli cellular agriculture start-up founded by Didier Toubia and Shulamit Levenberg in 2017 developing technologies for culturing meat products into 3D structures.
4
Funding Rounds
$119.8m
Money raised
Upside Foods is a San Francisco-based company making cultured meat products. The company was founded by Uma Valeti, Nicholas Genovese, and Will Clem.
4
Funding Rounds
$580.8m
Money raised
Senti Biosciences is a synthetic biology company.
2
Funding Rounds
$158.0m
Money raised
A cellular agriculture company making fresh and frozen cultured seafood products.
5
Funding Rounds
$104.5m
Money raised
Meatable is a cellular agriculture company making 100 percent clean meat products.
11
Funding Rounds
$256.5m
Money raised
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.
1
Funding Rounds
$225.0m
Money raised
RoosterBio is a biotechnology company located in Frederick, Maryland, founded by Jon Rowley in 2013 providing standardized stem cell products for R&D, clinical, and commercial use in the regenerative medicine industry.
3
Funding Rounds
$21.5m
Money raised
Orig3n is a biotechnology company developing personalized regenerative medicine treatments based on patient genetic profiles.
5
Funding Rounds
$111.8m
Money raised
Mosa Meat is a Dutch start-up company that makes and commercializes clean meat, meat made by growing animal cells directly rather than slaughtering animals.
6
Funding Rounds
$138.2m
Money raised
Integriculture is a Japanese cellular agriculture company making lab grown foie gras and other clean meat and cellular agriculture products. The company was founded in on October 23, 2015 and is located in Tokyo, Japan.
2
Funding Rounds
Scribe Therapeutics develops molecular engineering solutions for CRISPR-based genetic medicine.
2
Funding Rounds
$120.0m
Money raised
Prellis Biologics is developing technology to build transplantable human organs and tissues.
6
Funding Rounds
$88.0m
Money raised
SuperMeat is an Israeli biotechnology company, founded on December 15, 2015. SuperMeat is working to develop chicken meat products cultured from extracted chicken cells.
2
Funding Rounds
$3.2m
Money raised
Uncommon, formerly known as Higher Steaks, is a cellular agriculture company based in London, England founded in 2017 by Benjamina Bollag, Stephanie Wallis and David Hay working to develop pork and other meat products using cellular agriculture.
3
Funding Rounds
$60.0m
Money raised
EpiBone is a biotechnology startup company developing bone reconstruction solutions using stem cells. Nina Tandon, Sarindr Bhumiratana, Gordana Vunjak-Novakovic, and Sidney Eisig founded EpiBone in 2013 and the company is headquartered in New York City, New York.
1
Funding Rounds
Silicon Valley-based genetic engineering startup.
8
Funding Rounds
$459.7m
Money raised
Shiok Meats is a Singapore-based cellular agriculture company focusing on making cultured seafood.
5
Funding Rounds
$20.4m
Money raised
Develops novel cell and gene therapies with pharmacologic operating systems.
2
Funding Rounds
$164.5m
Money raised
Wild Type is a San Francisco based company producing meat products like salmon using cellular agriculture lab techniques.
4
Funding Rounds
$119.5m
Money raised
Mission Barns is a clean meat company company is headquartered in Berkeley, California producing clean meat. The company was founded in March, 2018, by Eitan Fischer (former director of cellular agriculture of JUST, Inc) and David Bowman.
5
Funding Rounds
$27.5m
Money raised
Company manufacturing 3d printed pharmaceuticals based in San Francisco, CA
4
Funding Rounds
$30.0m
Money raised
Bit.bio is a biotechnology company that aims to operate within human cells through means of coding and biology.
3
Funding Rounds
$183.9m
Money raised
Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.
4
Funding Rounds
$7.1m
Money raised
Dyno Therapeutics is a company based in Cambridge, Massachusetts applying artificial intelligence to gene therapy, focused on adeno-associated virus capsid engineering.
3
Funding Rounds
$109.0m
Money raised
Aegle Therapeutics Corporation, a regenerative medicine company isolating extracellular vesicles ("EVs") from allogeneic bone marrow derived mesenchymal stem cells (MSCs) to treat severe dermatological conditions, including burns and epidermolysis bullosa (“EB”).
5
Funding Rounds
$14.5m
Money raised
Tempo Therapeutics is an interventional biomaterials for regenerative medicine company founded by Westbrook Weaver.
1
Funding Rounds
$3.9m
Money raised
A cellular agriculture company creating meat cultured from animal cells.
7
Funding Rounds
$34.7m
Money raised
Coave Therapeutics is a genetic medicines developer founded in 2014.
6
Funding Rounds
$94.2m
Money raised
Kyverna is a cell therapy company engineering a new class of curative living medicines for inflammatory and autoimmune diseases.
2
Funding Rounds
$110.0m
Money raised
Ossium is building the world's first bone marrow bank to treat blood cancers, improve organ transplantation, and repair damage
3
Funding Rounds
$73.4m
Money raised
Immusoft is a biotechnology company developing a platform for the insertion of therapeutic genes into immune cells for the treatment of a variety of genetic diseases.
11
Funding Rounds
$37.9m
Money raised
Asimov is a startup that programs living cells with genetic circuits.
1
Funding Rounds
$4.7m
Money raised
Embody, Inc. is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address unmet needs in soft tissue restoration and regeneration.
3
Funding Rounds
$15.4m
Money raised
AGT is developing and commercializing gene and cell therapy and targeting major diseases, including HIV/AIDS, Phenylketonuria (PKU) and Hepatocellular carcinoma.
4
Funding Rounds
$6.0m
Money raised
Mekonos is a company that creates cell-engineering platforms
3
Funding Rounds
$31.0m
Money raised
Excision BioTherapeutics is a company founded in 2015 and headquartered in Philadelphia.
3
Funding Rounds
$70.8m
Money raised
Spark Therapeutics is a Philadelphia-based therapeutics and biotechnology company founded in 2013.
2
Funding Rounds
$122.8m
Money raised
Encoded Therapeutics is a developer of genomics-driven precision medicine targeting and treating genetic diseases and disorders.
4
Funding Rounds
$343.1m
Money raised
Gel4Med is a medical technology company developing biomaterials for the treatment and regeneration of tissues. It has developed an antimicrobial tissue-scaffolding matrix that promotes regeneration while shielding the tissues from bacteria. Manav Mehta founded the company in Boston, Massachusetts in 2015.
1
Funding Rounds
$200.0k
Money raised
Aspect Biosystems is a 3D bioprinting founded in 2013 by Tamer Mohamed, Konrad Walus, Sam Wadsworth and Simon Beyer.
1
Funding Rounds
$20.0m
Money raised
Cellares is a biotechnology and cell therapy company founded in 2019 by Fabian Gerlinghaus, Alex Pesch, and Omar Kurdi.
1
Funding Rounds
$82.0m
Money raised
Forge is a gene therapy development engine, focused on enabling access to life changing gene therapies and helping bring them from idea into reality.
2
Funding Rounds
$160.0m
Money raised
Arbor Technologies is a company in Cambridge, MA, focusing on biodiscovery using machine learning, genome sequencing, gene synthesis and high-throughput screening.
1
Funding Rounds
$215.0m
Money raised
Frontier Bio is a Hayward, California-based biotechnology research company developing lab-grown tissues to replace animal tissues.
1
Funding Rounds
$1.3m
Money raised
Emendo Biotherapeutics is a New York City-based biotechnology and synthetic biology company.
1
Funding Rounds
$61.0m
Money raised
Semma Therapeutics is a biotechnology company making regenerative medicine therapies using stem cells.
2
Funding Rounds
$114.0m
Money raised
Kytopen is a mircrofluidics company founded in 2017 by Paulo Garcia.
9
Funding Rounds
$42.4m
Money raised
Cellino (also known as Cellino Biotech) is a Cambridge, MA-based biotechnology company.
6
Funding Rounds
$93.1m
Money raised
Aspen Neuroscience develops autologous iPSC-derived cell replacement therapies for Parkinson’s disease and other CNS disorders.
3
Funding Rounds
$224.0m
Money raised
Minerva Biotechnologies is a clinical-stage biopharmaceutical company focused on developing immunotherapies for solid tumor cancers and cellular therapies for regenerative medicine.
8
Funding Rounds
$113.7m
Money raised
Rokit Healthcare Inc. is a 4D Bioprinting and Biotechnology company.
3
Funding Rounds
$30.0m
Money raised
SparingVision is a retinal Gene Therapy Treatments founded by Jose alain sahel.
2
Funding Rounds
$97.5m
Money raised
iVexSol is a newly formed viral vector manufacturing company
2
Funding Rounds
$15.0m
Money raised
Healios is a biotechnology company developing stem cell regenerative medicine therapies for the treatment of retinal and age-related macular diseases.
1
Funding Rounds
$9.9m
Money raised
ReCode Therapeutics is a genetic medicines company that specializes in mRNA and gene correction therapeutics.
5
Funding Rounds
$298.0m
Money raised
Creating custom growth media solutions for the cellular agriculture industry.
2
Funding Rounds
$13.4m
Money raised
Locanabio is a San Diego, California-based biotechnology company developing RNA-targeting gene therapies.
4
Funding Rounds
$210.6m
Money raised
Cell therapy firm specializing in developing treatments using advanced cellular technology.
6
Funding Rounds
$474.7m
Money raised
Gourmey is France's first cultivated meat company. Its mission is to accelerate the world’s transition toward humane, sustainable, and healthy meat by harvesting it from animal cells.
4
Funding Rounds
$68.2m
Money raised
TreeFrog Therapeutics aims at making iPS-derived cell therapies safer, more efficient and more affordable.
3
Funding Rounds
$157.3m
Money raised
Cubic Foods is a Barcelona-based food technology company growing cell-based specialty fats.
2
Funding Rounds
$19.6m
Money raised
I Peace is a technology company that provides research and development services for GMP products, drug discovery, and personal iPSC banking.
3
Funding Rounds
$35.3m
Money raised
ElevateBio is a company founded by Vikas Sinha, David Hallal and Melissa Carpenter.
2
Funding Rounds
$695.0m
Money raised
Avant Meats is developing cell cultured fish maw (aka dried fish bladder), a delicacy in traditional Chinese cuisine. Fish maw is typically sourced from either the Chinese Bahaba (giant yellow croaker) or the Totoaba, both of which are on the brink of extinction due to such high demand for fish maw. Avant Meats will source cells from the Chinese Bahaba fish.
2
Funding Rounds
$13.9m
Money raised
A company developing magnetic cell culture technology solutions for three-dimensional (3D) cell culture
1
Funding Rounds
$250.0k
Money raised
Novel class of off-the-shelf cancer immunotherapies based on a proprietary Plasmacytoid Dendritic Cell line pre-loaded with peptides
2
Funding Rounds
$43.9m
Money raised